University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

News

Feature: Biorepository and Tissue Biomarker Technology (BTBMT) Core

Feature: Biorepository and Tissue Biomarker Technology (BTBMT) Core

March 13, 2019

The goal of the Biorepository and Tissue Biomarker Technology Shared Resource (BTBMT) is to provide the infrastructure to support the life cycle and QA/QC of high quality biospecimens for cancer research. The multifaceted life cycle includes patient consenting, biospecimen acquisition, processing, storage, and distribution. The ...
Highlights from the Precision Medicine World Conference 2019

Highlights from the Precision Medicine World Conference 2019

March 1, 2019

For the fourth year, UCSF co-hosted the Precision Medicine World Conference, which attracted attendees from 35 countries to hear about the growing prominence of data science, artificial intelligence, and deep learning that is creating a sea change in nearly every aspect of health care and biomedical ...

 


image

Soft Drink Companies Copy Tobacco Playbook to Lure Young Users

March 14, 2019

Tobacco conglomerates that used colors, flavors and marketing techniques to entice children as future smokers transferred these same strategies to sweetened beverages when they bought food and drinks companies starting in 1963, according to a study by researchers at UC San Francisco. The study, which ...
UCSF Oncologist Answers Pancreas Cancer FAQs on Facebook Live

UCSF Oncologist Answers Pancreas Cancer FAQs on Facebook Live

March 13, 2019

Following the self-disclosure of Jeopardy's Alex Trebek that he is battling pancreas cancer, ABC7 News sat down with UCSF's Dr. Andrew Ko at our Mission Bay campus to discuss common questions about the disease. During the 30-minute Facebook Live broadcast, Dr. Ko discussed common side effects of treatment, ...
Q & A with Thea Tlsty, PhD, on Leading International Team to Study Inflammation and Cancer

Q & A with Thea Tlsty, PhD, on Leading International Team to Study Inflammation and Cancer

January 29, 2019

Thea D. Tlsty, PhD, Professor of Pathology and a UCSF leader in cell cycling and signaling, received a $26 million Grand Challenge Grant from Cancer Research UK (CRUK) to lead an international team exploring how chronic inflammation causes cancer.